Pyrrolotriazine derivatives for treating kit-and pdgframediated diseases

PH12021552568B1Active Publication Date: 2026-11-06BLUEPRINT MEDICINES CORP
0 Cites 0 Cited by

Patent Information

Application Number
PH12021552568
Authority / Receiving Office
PH · PH
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-10-07
Publication Date
2026-11-06
Estimated Expiration
2041-10-07
Patent Text Reader

Abstract

The present disclosure provides compounds of Formula I, pharmaceutical salts thereof, and / or solvates of any of the foregoing, which are useful for treating diseases and conditions related to mutant KIT and PDGFRα and present an advantageously non-brain penetrant profile for treating diseases and conditions related to mutant KIT and PDGFRα. The present disclosure also provides methods for treating gastrointestinal stromal tumors and systemic mastocytosis.
Need to check novelty before this filing date? Find Prior Art